Bunkerhill Health

Bunkerhill Health, previously known as BunkerHill and BunkerHill Health, operates from Palo Alto, CA, and employs a team of 12. As a participant in the Y-Combinator W19 batch, the company has garnered support from notable investors including Sequoia, Max Levchin, YC, DCVC, and Pacific8. Bunkerhill Health has established a consortium with prestigious research institutions such as Stanford, Johns Hopkins, and Harvard to facilitate the FDA clearance and commercial sales of AI algorithms. These algorithms have been successfully integrated and deployed across major health systems like UCSF, Mayo Clinic, and Georgetown/MedStar. The company offers a platform that trains, validates, and distributes AI algorithms specifically designed for healthcare applications. One of its notable innovations includes an automated AI solution for coronary artery calcium scoring on non-contrast chest CTs, which has demonstrated high predictive values in multiple health systems. Additionally, Bunkerhill Health aims to enhance lung cancer screening programs by integrating cardiovascular problem screening, supported by a clinical workflow for investigational use.